Pharmacokinetics and pharmacodynamics of fosmidomycin monotherapy and combination therapy with clindamycin in the treatment of multidrug resistant falciparum malaria
Open Access
- 25 May 2007
- journal article
- clinical trial
- Published by Springer Nature in Malaria Journal
- Vol. 6 (1) , 70
- https://doi.org/10.1186/1475-2875-6-70
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Bioassay for determination of fosmidomycin in plasma and urine: Application for pharmacokinetic dose optimisationJournal of Microbiological Methods, 2007
- Fosmidomycin plus Clindamycin for Treatment of Pediatric Patients Aged 1 to 14 Years with Plasmodium falciparum MalariaAntimicrobial Agents and Chemotherapy, 2006
- Fosmidomycin‐Clindamycin forPlasmodium falciparumInfections in African ChildrenThe Journal of Infectious Diseases, 2004
- IN VITRO METABOLISM OF CLINDAMYCIN IN HUMAN LIVER AND INTESTINAL MICROSOMESDrug Metabolism and Disposition, 2003
- Fosmidomycin, a Novel Chemotherapeutic Agent for MalariaAntimicrobial Agents and Chemotherapy, 2003
- In Vitro and In Vivo Synergy of Fosmidomycin, a Novel Antimalarial Drug, with ClindamycinAntimicrobial Agents and Chemotherapy, 2002
- Inhibitors of the Nonmevalonate Pathway of Isoprenoid Biosynthesis as Antimalarial DrugsScience, 1999
- A Plastid of Probable Green Algal Origin in Apicomplexan ParasitesScience, 1997
- Clindamycin Dose-Bioavailability RelationshipsJournal of Pharmaceutical Sciences, 1973
- Absorption, Excretion and Half-Life of Clinimycin in Normal Adult MalesThe Lancet Healthy Longevity, 1968